General Comments / Chat, page-10517

Totally forgot where I came from for a sec and took freedom of speech for granted...LOL...

BTW, Prof. Ngo comes from the same background just in case you have forgotten mine. Have been sincerely proud since she started working with Race, then her Game Changer Award and now this cardio protection synergy paper.

Anyways, back to First World problem !

Now that our cardio protection valuation has increased by ~300% (your estimate), how do we explain that to BPs ? We already have problems convincing people to buy our shares at a 50% discount value from Triangle report. So now, do we also apply ~300% increase to FTO valuation because it's supposed to be the same as cardio protection or do we just leave it alone ? I'm starting to think my USD300 ps is like 30c to a dollar.

Surely that's a huge blockbuster drug potential for any biotech companies. I'm the one that wrote about Dr. T being completely strategic so yes, I do totally understand. But rather than presenting digital dentistry, lets get out there, sing bisantrene's song (just the usual published lyrics), push that narrative and convince people about bisantrene, it's super power, reference Prof. Ngo's work/paper and it's potential so we can raise more awareness about Race Oncology.